{"transactions":[{"id":3550839,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-08T21:20:35.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":21852,"price":0.82,"value":17918.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 3, 2026 Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 3, 2026 Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include 1,031,944 shares of the Issuer's common stock held by Mr. Chan directly, and certain other securities held indirectly through various entities."}],"balance_after":1031944,"source":{"system":"sec-edgar","filing":"0001493152-26-041798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261725/000149315226041798/ownership.xml","form_type":"4"}},{"id":712237,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25403,"kind":"organization","name":"Alset International Ltd","position":3,"cik":"0001660984","reported_name":"Alset International Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2026-07-09T21:00:02.000Z","date":"2026-06-03","kind":"other","planned":false,"acquired":true,"shares":16554055,"price":0.93,"value":15395271.15,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On March 26, 2026 the Issuer issued common stock purchase warrants (the \"Warrants\") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share. The Warrants expire on March 26, 2031."},{"field":"shares","element":"transactionShares","label":"F2","text":"On March 26, 2026 the Issuer issued common stock purchase warrants (the \"Warrants\") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share. The Warrants expire on March 26, 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 26, 2026 the Issuer issued common stock purchase warrants (the \"Warrants\") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share. The Warrants expire on March 26, 2031."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On March 26, 2026 the Issuer issued common stock purchase warrants (the \"Warrants\") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share. The Warrants expire on March 26, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include the following shares held personally (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Mr. Chan may also be deemed to beneficially own (a) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (b) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (c) 1,068,309 shares of the Issuer's common stock, a convertible promissory note in the amount of $2,450,000, and common stock purchase warrants to purchase up to 16,554,055 shares held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (d) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include the following shares held personally (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Chan may also be deemed to beneficially own (a) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (b) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (c) 1,068,309 shares of the Issuer's common stock, a convertible promissory note in the amount of $2,450,000, and common stock purchase warrants to purchase up to 16,554,055 shares held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (d) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"balance_after":16554055,"derivative":{"exercise_date":"2026-06-03","expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":16554055},"source":{"system":"sec-edgar","filing":"0001493152-26-032712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/ownership.xml","form_type":"4"}},{"id":712236,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25403,"kind":"organization","name":"Alset International Ltd","position":3,"cik":"0001660984","reported_name":"Alset International Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-07-09T21:00:02.000Z","date":"2026-06-03","kind":"other","planned":false,"acquired":true,"price":0.74,"reported_value":2450000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 26, 2026 the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 26, 2026 the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"On March 26, 2026 the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 26, 2026 the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On March 26, 2026 the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F3","text":"The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include the following shares held personally (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F4","text":"Mr. Chan may also be deemed to beneficially own (a) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (b) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (c) 1,068,309 shares of the Issuer's common stock, a convertible promissory note in the amount of $2,450,000, and common stock purchase warrants to purchase up to 16,554,055 shares held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (d) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include the following shares held personally (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Chan may also be deemed to beneficially own (a) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (b) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (c) 1,068,309 shares of the Issuer's common stock, a convertible promissory note in the amount of $2,450,000, and common stock purchase warrants to purchase up to 16,554,055 shares held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (d) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"derivative":{"exercise_date":"2026-06-03","expiration_date":"2031-03-26","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001493152-26-032712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/ownership.xml","form_type":"4"}},{"id":1052306,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T01:43:10.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":true,"shares":130679,"price":1.3475,"value":176089.9525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 28, 2025, Mr. Chan sold 130,679 shares of the Issuer's common stock at an average sale price of $1.3475. The shares were sold in multiple trades at prices ranging between $1.23 and $1.565. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 28, 2025, Mr. Chan sold 130,679 shares of the Issuer's common stock at an average sale price of $1.3475. The shares were sold in multiple trades at prices ranging between $1.23 and $1.565. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan may be deemed to include the following: (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,053,796 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"balance_after":1053796,"source":{"system":"sec-edgar","filing":"0001641172-25-026292","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000164117225026292/ownership.xml","form_type":"4"}},{"id":1052305,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-09-03T01:30:46.000Z","date":"2025-08-20","kind":"other","planned":false,"acquired":true,"reported_value":500000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Amended Form 4 is being filed to clarify certain information set forth on the Form 4 originally filed by the reporting persons on August 22, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Promissory Note\") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F3","text":"The beneficial ownership of Mr. Chan as of August 22, 2025 may be deemed to include the following (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The beneficial ownership of Mr. Chan as of August 22, 2025 may be deemed to include the following (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"derivative":{"exercise_date":"2025-08-20","expiration_date":"2028-07-31","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001641172-25-026290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000164117225026290/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-22"}},{"id":1058811,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T23:30:36.000Z","date":"2025-08-20","kind":"other","planned":false,"acquired":true,"shares":581395,"price":0.86,"value":499999.7,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Note\") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Note\") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Note\") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan includes a total of 6,730,059 shares of common stock, consisting of (a) 1,002,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock and debt convertible into 581,395 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On August 20, 2025, the Issuer issued a convertible promissory note (the \"Convertible Note\") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share."}],"balance_after":581395,"derivative":{"exercise_price":0.86,"exercise_date":"2025-08-20","expiration_date":"2028-07-31","underlying":"Common Stock","underlying_shares":581395},"source":{"system":"sec-edgar","filing":"0001641172-25-025294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000164117225025294/ownership.xml","form_type":"4"}},{"id":1277735,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-10T23:14:34.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2025, the Issuer awarded Mr. Heng Fai Ambrose Chan, a Director of the Company, a stock grant of 1,000,000 newly issued shares of the Issuer's common stock through his personally owned company, Heng Fai Holdings Limited as compensation for services rendered. The common stock was issued pursuant to the Issuer's 2020 Employee, Director and Consultant Equity Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2025, the Issuer awarded Mr. Heng Fai Ambrose Chan, a Director of the Company, a stock grant of 1,000,000 newly issued shares of the Issuer's common stock through his personally owned company, Heng Fai Holdings Limited as compensation for services rendered. The common stock was issued pursuant to the Issuer's 2020 Employee, Director and Consultant Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan includes a total of 6,148,664 shares of common stock, consisting of (a) 1,002,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2025, the Issuer awarded Mr. Heng Fai Ambrose Chan, a Director of the Company, a stock grant of 1,000,000 newly issued shares of the Issuer's common stock through his personally owned company, Heng Fai Holdings Limited as compensation for services rendered. The common stock was issued pursuant to the Issuer's 2020 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":1002978,"source":{"system":"sec-edgar","filing":"0001493152-25-005715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315225005715/ownership.xml","form_type":"4"}},{"id":1334669,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-13T02:49:45.000Z","date":"2024-12-10","kind":"purchase","planned":false,"acquired":true,"shares":205149,"price":0.9749,"value":199999.7601,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 10, 2024, Alset Inc. entered into a stock purchase agreement with DSS, Inc. (the \"Issuer\"), pursuant to which Alset Inc. agreed to purchase 820,597 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Alset Inc. and its various subsidiaries are collectively the largest shareholder of DSS. Further, on December 10, 2024, Mr. Chan directly entered into a stock purchase agreement with the Issuer, pursuant to which he agreed to purchase 205,149 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Mr. Chan is the Executive Chairman of DSS."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 10, 2024, Alset Inc. entered into a stock purchase agreement with DSS, Inc. (the \"Issuer\"), pursuant to which Alset Inc. agreed to purchase 820,597 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Alset Inc. and its various subsidiaries are collectively the largest shareholder of DSS. Further, on December 10, 2024, Mr. Chan directly entered into a stock purchase agreement with the Issuer, pursuant to which he agreed to purchase 205,149 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Mr. Chan is the Executive Chairman of DSS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan includes a total of 5,148,664 shares of common stock, consisting of (a) 2,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"balance_after":1184475,"source":{"system":"sec-edgar","filing":"0001493152-24-049861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315224049861/ownership.xml","form_type":"4"}},{"id":1334668,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-13T02:49:45.000Z","date":"2024-12-10","kind":"purchase","planned":false,"acquired":true,"shares":820597,"price":0.9749,"value":800000.0153,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 10, 2024, Alset Inc. entered into a stock purchase agreement with DSS, Inc. (the \"Issuer\"), pursuant to which Alset Inc. agreed to purchase 820,597 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Alset Inc. and its various subsidiaries are collectively the largest shareholder of DSS. Further, on December 10, 2024, Mr. Chan directly entered into a stock purchase agreement with the Issuer, pursuant to which he agreed to purchase 205,149 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Mr. Chan is the Executive Chairman of DSS."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 10, 2024, Alset Inc. entered into a stock purchase agreement with DSS, Inc. (the \"Issuer\"), pursuant to which Alset Inc. agreed to purchase 820,597 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Alset Inc. and its various subsidiaries are collectively the largest shareholder of DSS. Further, on December 10, 2024, Mr. Chan directly entered into a stock purchase agreement with the Issuer, pursuant to which he agreed to purchase 205,149 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Mr. Chan is the Executive Chairman of DSS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Mr. Chan includes a total of 5,148,664 shares of common stock, consisting of (a) 2,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The beneficial ownership of Mr. Chan includes a total of 5,148,664 shares of common stock, consisting of (a) 2,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.)."}],"balance_after":3961211,"source":{"system":"sec-edgar","filing":"0001493152-24-049861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315224049861/ownership.xml","form_type":"4"}},{"id":1697412,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T21:15:33.000Z","date":"2023-12-29","kind":"sale","planned":false,"acquired":false,"shares":1020,"price":0.131,"value":133.62,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-000089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315224000089/ownership.xml","form_type":"4"}},{"id":1697411,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T21:15:33.000Z","date":"2023-12-29","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":0.131,"value":19650.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned and sold by Mr. Wu's spouse. Mr. Wu disclaimed beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-000089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315224000089/ownership.xml","form_type":"4"}},{"id":1697413,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T14:10:36.000Z","date":"2023-12-28","kind":"purchase","planned":false,"acquired":true,"shares":672173,"price":0.146,"value":98137.258,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 28, 2023, the reporting person purchased 672,173 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1239 to $0.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 28, 2023, the reporting person purchased 672,173 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1239 to $0.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes a total of 82,458,315 shares of common stock, consisting of (a) 59,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 19,586,499 shares of common stock held by Heng Fai Chan directly; (c) 35,213,416 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 21,366,177 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited."}],"balance_after":19586499,"source":{"system":"sec-edgar","filing":"0001493152-24-000039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315224000039/ownership.xml","form_type":"4"}},{"id":1918596,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":85298,"kind":"person","name":"Heuszel Frank D","position":1,"cik":"0001748704","reported_name":"Heuszel Frank D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-18T20:05:28.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":1247078,"price":0.2168,"value":270366.5104,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 10, 2023, Frank D. Heuszel was issued 1,247,078 shares of common stock pursuant to his employment agreement."}],"balance_after":1312776,"source":{"system":"sec-edgar","filing":"0001493152-23-012781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315223012781/ownership.xml","form_type":"4"}},{"id":2087106,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T01:39:39.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":334921,"price":0.2266,"value":75893.0986,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 13, 2022, the reporting person purchased 334,921 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1899 to $0.25. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 13, 2022, the reporting person purchased 334,921 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1899 to $0.25. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes a total of 81,786,142 shares of common stock, consisting of (a) 59,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 18,914,326 shares of common stock held by Heng Fai Chan directly; (c) 35,213,416 shares of common stock held by Alset Inc.; (d) 21,366,177 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc.; and (e) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset Inc., Alset International Limited and Global Biomedical Pte. Ltd."}],"balance_after":18914326,"source":{"system":"sec-edgar","filing":"0001493152-22-035493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222035493/ownership.xml","form_type":"4"}},{"id":2088987,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:30:31.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":51385,"price":0.1931,"value":9922.4435,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 9, 2022, the reporting person purchased 51,385 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1866 to $0.195. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 9, 2022, the reporting person purchased 51,385 shares of the Issuer's common stock. This transaction was executed in multiple trades at prices ranging from $0.1866 to $0.195. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes a total of 81,451,221 shares of common stock, consisting of (a) 59,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 18,579,405 shares of common stock held by Heng Fai Chan directly; (c) 35,213,416 shares of common stock held by Alset Inc.; (d) 21,366,177 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc.; and (e) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset Inc., Alset International Limited and Global Biomedical Pte. Ltd."}],"balance_after":18579405,"source":{"system":"sec-edgar","filing":"0001493152-22-035312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222035312/ownership.xml","form_type":"4"}},{"id":2207757,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset EHome International Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25403,"kind":"organization","name":"Alset International Ltd","position":3,"cik":"0001660984","reported_name":"Alset International Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T01:12:54.000Z","date":"2022-07-12","kind":"other","acquired":true,"shares":21366177,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 12, 2022, Alset International Limited (\"AIL\"), a majority owned subsidiary of Alset EHome International Inc. (\"AEI\"), was issued 21,366,177 shares of the common stock of DSS, Inc. (the \"Issuer\") pursuant to an assignment and assumption agreement (the \"Agreement\") between the Issuer and AIL dated February 25, 2022, as amended on July 12, 2022. Pursuant to the Agreement, as amended, the Issuer agreed to purchase a convertible promissory note from AIL (the \"Note\"). The Note has a principal amount of $8,350,000 and accrued but unpaid interest of $367,400. The Note was issued by American Medical REIT, Inc., a Maryland corporation. The consideration paid for the Note was 21,366,177 shares of the Issuer's common stock. The consideration was calculated by dividing $8,717,400, the aggregate of the principal amount and the accrued but unpaid interest under the Note, by $0.408 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 12, 2022, Alset International Limited (\"AIL\"), a majority owned subsidiary of Alset EHome International Inc. (\"AEI\"), was issued 21,366,177 shares of the common stock of DSS, Inc. (the \"Issuer\") pursuant to an assignment and assumption agreement (the \"Agreement\") between the Issuer and AIL dated February 25, 2022, as amended on July 12, 2022. Pursuant to the Agreement, as amended, the Issuer agreed to purchase a convertible promissory note from AIL (the \"Note\"). The Note has a principal amount of $8,350,000 and accrued but unpaid interest of $367,400. The Note was issued by American Medical REIT, Inc., a Maryland corporation. The consideration paid for the Note was 21,366,177 shares of the Issuer's common stock. The consideration was calculated by dividing $8,717,400, the aggregate of the principal amount and the accrued but unpaid interest under the Note, by $0.408 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes 81,399,836 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 16,973,020 shares of common stock held by Heng Fai Chan directly; (c) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of AIL; (d) 35,213,416 shares of common stock held by Alset EHome International Inc.; and (e) 21,366,177 shares of common stock held by AIL, a subsidiary of Alset EHome International Inc. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset EHome International Inc., Global Biomedical Pte. Ltd., and Alset International Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes 81,399,836 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 16,973,020 shares of common stock held by Heng Fai Chan directly; (c) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of AIL; (d) 35,213,416 shares of common stock held by Alset EHome International Inc.; and (e) 21,366,177 shares of common stock held by AIL, a subsidiary of Alset EHome International Inc. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset EHome International Inc., Global Biomedical Pte. Ltd., and Alset International Limited."}],"balance_after":81399836,"source":{"system":"sec-edgar","filing":"0001493152-22-019369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222019369/ownership.xml","form_type":"4"}},{"id":2209503,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset EHome International Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:34:21.000Z","date":"2022-07-07","kind":"purchase","acquired":true,"shares":17570948,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 7, 2022, Alset EHome International Inc. (\"AEI\") was issued 17,570,948 shares of common stock pursuant to a Stock Purchase Agreement (\"SPA\") between the Issuer and AEI dated February 28, 2022. Pursuant to the SPA, AEI agreed to sell a subsidiary holding 44,808,908 shares of stock of True Partner Capital Holding Limited, together with an additional 17,314,000 shares of True Partner Capital Holding Limited (for a total of 62,122,908 shares) in exchange for the 17,570,948 shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes 60,033,659 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 16,973,020 shares of common stock held by Heng Fai Chan directly; (c) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd.; and (d) 35,213,416 shares of common stock held by Alset EHome International Inc. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset EHome International Inc. and Global Biomedical Pte. Ltd. Global Biomedical Pte. Ltd. is a subsidiary of an entity which is majority-owned by Alset EHome International Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes 60,033,659 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 16,973,020 shares of common stock held by Heng Fai Chan directly; (c) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd.; and (d) 35,213,416 shares of common stock held by Alset EHome International Inc. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset EHome International Inc. and Global Biomedical Pte. Ltd. Global Biomedical Pte. Ltd. is a subsidiary of an entity which is majority-owned by Alset EHome International Inc."}],"balance_after":60033659,"source":{"system":"sec-edgar","filing":"0001493152-22-019013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222019013/ownership.xml","form_type":"4"}},{"id":2226241,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:50:41.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":5000,"price":0.3775,"value":1887.5,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":151020,"source":{"system":"sec-edgar","filing":"0001493152-22-017420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222017420/ownership.xml","form_type":"4"}},{"id":2226240,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:50:41.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":5000,"price":0.38,"value":1900.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":146020,"source":{"system":"sec-edgar","filing":"0001493152-22-017420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222017420/ownership.xml","form_type":"4"}},{"id":2233439,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T21:23:53.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":27000,"price":0.41,"value":11070.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Based on price at market close. The average purchase price for 140,000 shares was $0.4136."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001493152-22-016767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222016767/ownership.xml","form_type":"4"}},{"id":2233438,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T21:23:53.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":72600,"price":0.415,"value":30129.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Based on price at market close. The average purchase price for 140,000 shares was $0.4136."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":113000,"source":{"system":"sec-edgar","filing":"0001493152-22-016767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222016767/ownership.xml","form_type":"4"}},{"id":2233437,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T21:23:53.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":23651,"price":0.408,"value":9649.608,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Based on price at market close. The average purchase price for 140,000 shares was $0.4136."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":40400,"source":{"system":"sec-edgar","filing":"0001493152-22-016767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222016767/ownership.xml","form_type":"4"}},{"id":2233436,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24459,"kind":"person","name":"Wu William Wai Leung","position":1,"cik":"0001793749","reported_name":"Wu William Wai Leung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T21:23:53.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":16749,"price":0.39,"value":6532.11,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Based on price at market close. The average purchase price for 140,000 shares was $0.4136."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Owned and purchased by Mr. Wu's spouse. Mr. Wu disclaims beneficial ownership of these securities."}],"balance_after":16749,"source":{"system":"sec-edgar","filing":"0001493152-22-016767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222016767/ownership.xml","form_type":"4"}},{"id":2250311,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":85298,"kind":"person","name":"Heuszel Frank D","position":1,"cik":"0001748704","reported_name":"Heuszel Frank D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-01T12:57:40.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":63205,"price":0.45,"value":28442.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2022, Frank D. Heuszel was issued 63,205 shares of common stock pursuant to his employment agreement. Such shares were issued as payment of a performance bonus due under such employment agreement."}],"balance_after":65698,"source":{"system":"sec-edgar","filing":"0001493152-22-015542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222015542/ownership.xml","form_type":"4"}},{"id":2254574,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:15:57.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15389995,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 25, 2022, Heng Fai Ambrose Chan was issued 15,389,995 shares of common stock pursuant to his employment agreement. Such shares were issued as payment of base salary and a performance bonus due under such employment agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 25, 2022, Heng Fai Ambrose Chan was issued 15,389,995 shares of common stock pursuant to his employment agreement. Such shares were issued as payment of base salary and a performance bonus due under such employment agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Ambrose Chan includes 42,462,711 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Ambrose Chan; (b) 16,973,020 shares of common stock held by Heng Fai Ambrose Chan directly; (c) 6,232,671 shares of common stock held by Global Biomedical Pte. Ltd.; and (d) 17,642,468 shares of common stock held by Alset EHome International Inc."}],"balance_after":16973020,"source":{"system":"sec-edgar","filing":"0001493152-22-015360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222015360/ownership.xml","form_type":"4"}},{"id":2295274,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-19T20:21:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":894084,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2022, Heng Fai Chan was issued 894,084 shares of common stock pursuant to his employment agreement. Such shares were issued in consideration of $339,752 due under such employment agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 1, 2022, Heng Fai Chan was issued 894,084 shares of common stock pursuant to his employment agreement. Such shares were issued in consideration of $339,752 due under such employment agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The beneficial ownership of Heng Fai Chan includes 27,072,716 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,583,025 shares of common stock held by Heng Fai Chan directly; (c) 16,667 shares of common stock held by BMI Capital Partners International Limited; (d) 7,716,004 shares of common stock held by Global Biomedical Pte. Ltd.; and (e) 16,142,468 shares of common stock held by Alset EHome International Inc."}],"balance_after":1583025,"source":{"system":"sec-edgar","filing":"0001493152-22-010437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222010437/ownership.xml","form_type":"4"}},{"id":2340761,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset EHome International Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-11T01:26:45.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":3986877,"price":0.381,"value":1519000.137,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The beneficial ownership of Heng Fai Chan includes 26,178,632 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 688,941 shares of common stock held by Heng Fai Chan directly; (c) 16,667 shares of common stock held by BMI Capital Partners International Limited; (d) 7,716,004 shares of common stock held by Global Biomedical Pte. Ltd.; and (e) 16,142,468 shares of common stock held by Alset EHome International Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"16,142,468 shares of common stock are owned directly by Alset EHome International Inc., including 3,986,877 shares purchased on March 9, 2022 pursuant to an agreement entered into between Alset EHome International Inc. and DSS, Inc. on February 28, 2022. Mr. Chan, as indirect beneficial owner, has dispositive control over the securities of the Issuer owned by Alset EHome International Inc., BMI Capital Partners International Limited and Global Biomedical Pte. Ltd. BMI Capital Partners International Limited and Global Biomedical Pte. Ltd. are each subsidiaries of entities majority-owned by Alset EHome International Inc."}],"balance_after":26178632,"source":{"system":"sec-edgar","filing":"0001493152-22-006557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315222006557/ownership.xml","form_type":"4"}},{"id":2574076,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":7148,"kind":"organization","name":"Alset Inc.","position":2,"cik":"0001750106","reported_name":"Alset EHome International Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T21:12:03.000Z","date":"2021-09-08","kind":"purchase","acquired":true,"shares":12155591,"price":1.234,"value":14999999.294,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The beneficial ownership of Heng Fai Chan includes 22,191,755 shares of common stock, consisting of (a) 1,614,552 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 688,941 shares of common stock held by Heng Fai Chan directly; (c) 16,667 shares of common stock held by BMI Capital Partners International Limited; (d) 7,716,004 shares of common stock held by Global Biomedical Pte. Ltd.; and (e) 12,155,591 shares of common stock held by Alset EHome International Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These 12,155,591 shares of common stock are owned directly by Alset EHome International Inc. Mr. Chan has dispositive control over the securities of the Issuer owned by Alset EHome International Inc., BMI Capital Partners International Limited and Global Biomedical Pte. Ltd. BMI Capital Partners International Limited and Global Biomedical Pte. Ltd. are each subsidiaries of entities majority-owned by Alset EHome International Inc."}],"balance_after":22191755,"source":{"system":"sec-edgar","filing":"0001493152-21-022444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221022444/ownership.xml","form_type":"4"}},{"id":2657956,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-06-24T01:41:06.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":7259,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the Common Stock of the Issuer at a conversion price of $6.48 per share. Following the conversion of 7,259 shares of Series A Convertible Preferred Stock, GBM does not own any shares of Series A Convertible Preferred Stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 7,259 shares of Series A Convertible Preferred Stock into 1,120,170 shares of the common stock, par value $0.02 per share (the \"Common Stock\"), of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the Common Stock of the Issuer at a conversion price of $6.48 per share. Following the conversion of 7,259 shares of Series A Convertible Preferred Stock, GBM does not own any shares of Series A Convertible Preferred Stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the Common Stock of the Issuer at a conversion price of $6.48 per share. Following the conversion of 7,259 shares of Series A Convertible Preferred Stock, GBM does not own any shares of Series A Convertible Preferred Stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the Common Stock of the Issuer at a conversion price of $6.48 per share. Following the conversion of 7,259 shares of Series A Convertible Preferred Stock, GBM does not own any shares of Series A Convertible Preferred Stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities were owned directly by GBM. Mr. Chan has dispositive control over the securities of the Issuer owned by GBM."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1120170},"source":{"system":"sec-edgar","filing":"0001493152-21-015139","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221015139/ownership.xml","form_type":"4"}},{"id":2657955,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:41:06.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":1120170,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 7,259 shares of Series A Convertible Preferred Stock into 1,120,170 shares of the common stock, par value $0.02 per share (the \"Common Stock\"), of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the Common Stock of the Issuer at a conversion price of $6.48 per share. Following the conversion of 7,259 shares of Series A Convertible Preferred Stock, GBM does not own any shares of Series A Convertible Preferred Stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The beneficial ownership of the Reporting Person includes 10,036,164 shares of Common Stock, consisting of (a) 1,614,552 shares of Common Stock held by Heng Fai Holdings Limited; (b) 16,667 shares of Common Stock held by BMI Capital Partners International Limited; (c) 474,060 shares of Common Stock held by the Reporting Person; (d) 214,881 shares of Common Stock held by LiquidValue Development Pte Ltd.; and (e) 7,716,004 shares of Common Stock held by Global Biomedical Pte. Ltd."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities were owned directly by GBM. Mr. Chan has dispositive control over the securities of the Issuer owned by GBM."}],"balance_after":10036164,"source":{"system":"sec-edgar","filing":"0001493152-21-015139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221015139/ownership.xml","form_type":"4"}},{"id":2665087,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T22:44:45.000Z","date":"2021-06-16","kind":"purchase","acquired":true,"shares":555000,"price":1.7,"value":943500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The beneficial ownership of the Reporting Person includes, in addition to those purchases described herein, 7,392,012 shares of common stock, par value $0.02 per share, of Document Security Systems, Inc. (\"Common Stock\"), consisting of (a) 59,552 shares of Common Stock held by Heng Fai Holdings Limited; (b) 16,667 shares of Common Stock held by BMI Capital Partners International Limited; (c) 474,060 shares of Common Stock held by the Reporting Person; (d) 214,881 shares of Common Stock held by LiquidValue Development Pte Ltd.; and (e) (i) 6,595,834 shares of Common Stock and (ii) 31,018 shares of Common Stock that could be obtained upon the conversion of shares of Series A Convertible Preferred Stock, par value $.02 per share, beneficially owned by the Reporting Person, held by Global Biomedical Pte. Ltd."}],"balance_after":8947012,"source":{"system":"sec-edgar","filing":"0001493152-21-014712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221014712/ownership.xml","form_type":"4"}},{"id":2665086,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T22:44:45.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":884040,"price":1.69,"value":1494027.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The beneficial ownership of the Reporting Person includes, in addition to those purchases described herein, 7,392,012 shares of common stock, par value $0.02 per share, of Document Security Systems, Inc. (\"Common Stock\"), consisting of (a) 59,552 shares of Common Stock held by Heng Fai Holdings Limited; (b) 16,667 shares of Common Stock held by BMI Capital Partners International Limited; (c) 474,060 shares of Common Stock held by the Reporting Person; (d) 214,881 shares of Common Stock held by LiquidValue Development Pte Ltd.; and (e) (i) 6,595,834 shares of Common Stock and (ii) 31,018 shares of Common Stock that could be obtained upon the conversion of shares of Series A Convertible Preferred Stock, par value $.02 per share, beneficially owned by the Reporting Person, held by Global Biomedical Pte. Ltd."}],"balance_after":8392012,"source":{"system":"sec-edgar","filing":"0001493152-21-014712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221014712/ownership.xml","form_type":"4"}},{"id":2665085,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T22:44:45.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":115960,"price":1.77,"value":205249.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The beneficial ownership of the Reporting Person includes, in addition to those purchases described herein, 7,392,012 shares of common stock, par value $0.02 per share, of Document Security Systems, Inc. (\"Common Stock\"), consisting of (a) 59,552 shares of Common Stock held by Heng Fai Holdings Limited; (b) 16,667 shares of Common Stock held by BMI Capital Partners International Limited; (c) 474,060 shares of Common Stock held by the Reporting Person; (d) 214,881 shares of Common Stock held by LiquidValue Development Pte Ltd.; and (e) (i) 6,595,834 shares of Common Stock and (ii) 31,018 shares of Common Stock that could be obtained upon the conversion of shares of Series A Convertible Preferred Stock, par value $.02 per share, beneficially owned by the Reporting Person, held by Global Biomedical Pte. Ltd."}],"balance_after":7507972,"source":{"system":"sec-edgar","filing":"0001493152-21-014712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221014712/ownership.xml","form_type":"4"}},{"id":2694341,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-05-28T00:03:56.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":35316,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 33,120,125 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 201 shares of Series A Preferred Stock, equal to 31,018 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 35,316 shares of Series A Convertible Preferred Stock into 5,450,000 shares of the common stock of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 33,120,125 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 201 shares of Series A Preferred Stock, equal to 31,018 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 33,120,125 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 201 shares of Series A Preferred Stock, equal to 31,018 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 33,120,125 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 201 shares of Series A Preferred Stock, equal to 31,018 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by GBM. Mr. Chan has dispositive control over the common stock and Series A Convertible Preferred Stock of the Issuer owned by GBM."}],"balance_after":7259,"derivative":{"underlying":"Common Stock","underlying_shares":5450000},"source":{"system":"sec-edgar","filing":"0001493152-21-013109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221013109/ownership.xml","form_type":"4"}},{"id":2694340,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T00:03:56.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":5450000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 35,316 shares of Series A Convertible Preferred Stock into 5,450,000 shares of the common stock of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 33,120,125 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 201 shares of Series A Preferred Stock, equal to 31,018 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by GBM. Mr. Chan has dispositive control over the common stock and Series A Convertible Preferred Stock of the Issuer owned by GBM."}],"balance_after":6595834,"source":{"system":"sec-edgar","filing":"0001493152-21-013109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315221013109/ownership.xml","form_type":"4"}},{"id":3001117,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-23T21:56:11.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":4293,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 5,836,212 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 168 shares of Series A Preferred Stock, equal to 25,925 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 4,293 shares of Series A Convertible Preferred Stock into 662,500 shares of the common stock of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 5,836,212 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 168 shares of Series A Preferred Stock, equal to 25,925 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 5,836,212 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 168 shares of Series A Preferred Stock, equal to 25,925 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 5,836,212 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 168 shares of Series A Preferred Stock, equal to 25,925 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by GBM. Mr. Chan has dispositive control over the common stock and Series A Convertible Preferred Stock of the Issuer owned by GBM."}],"balance_after":42575,"derivative":{"underlying":"Common Stock","underlying_shares":662500},"source":{"system":"sec-edgar","filing":"0001493152-20-019900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220019900/ownership.xml","form_type":"4"}},{"id":3001116,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135598,"kind":"organization","name":"Global BioMedical Pte. Ltd.","position":2,"cik":"0001823066","reported_name":"Global BioMedical Pte. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T21:56:11.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":662500,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Global BioMedical Pte. Ltd. (\"GBM\") has converted 4,293 shares of Series A Convertible Preferred Stock into 662,500 shares of the common stock of Document Security Systems, Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Convertible Preferred Stock of the Issuer has a stated value of $1,000 per share and may be converted into shares of the common stock of the Issuer at a conversion price of $6.48 per share, subject to a 19.99% beneficial ownership conversion limitation (the \"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. There are currently 5,836,212 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently able to convert an additional 168 shares of Series A Preferred Stock, equal to 25,925 shares of the Issuer's common stock. Mr. Chan has dispositive control over the securities owned by GBM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by GBM. Mr. Chan has dispositive control over the common stock and Series A Convertible Preferred Stock of the Issuer owned by GBM."}],"balance_after":1145834,"source":{"system":"sec-edgar","filing":"0001493152-20-019900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220019900/ownership.xml","form_type":"4"}},{"id":3048164,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-08-26T00:29:21.000Z","date":"2020-08-21","kind":"other","acquired":true,"shares":46868,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In connection with the Exchange Agreement, GBM received 46,868 newly issued shares of the Issuer's Series A Convertible Preferred Stock (\"Series A Preferred Stock\") with a stated value of $46,868,000, or $1,000 per share. The Series A Preferred Stock is convertible into shares of common stock of DSS, at an initial conversion price of $6.48 per share, subject to a 19.9% beneficial ownership conversion limitation (\"Blocker\") based on the total issued and outstanding shares of common stock of the Issuer beneficially owned by GBM. As of August 21, 2020, there were 5,115,179 shares of the Issuer's common stock issued and outstanding, and therefore, as a result of the Blocker, GBM is currently only able to convert the number of Series A Preferred Stock equal to approximately 673,904 shares of the Issuer's common stock, or approximately 4,366 shares of Series A Preferred Stock. The Reporting Person has dispositive control over these securities."}],"balance_after":46868,"derivative":{"exercise_price":6.48,"underlying":"Common Stock","underlying_shares":7232716},"source":{"system":"sec-edgar","filing":"0001493152-20-016707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220016707/ownership.xml","form_type":"4"}},{"id":3048163,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T00:29:21.000Z","date":"2020-08-21","kind":"other","acquired":true,"shares":483334,"price":6.48,"value":3132004.32,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 21, 2020, Document Security Systems, Inc., a New York corporation (the \"Issuer\") closed on a share exchange agreement (the \"Exchange Agreement\") by and among the Issuer, DSS BioHealth Security, Inc., Singapore eDevelopment Ltd. (\"SeD\"), an entity controlled by the Reporting Person, and Global Biomedical Pte Ltd. (\"GBM\"), a wholly-owned subsidiary of SeD. Pursuant to the Exchange Agreement, GBM received 483,334 shares of the Issuer's common stock at a per share cost basis of $6.48 per share. The Reporting Person has dispositive control over these securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 21, 2020, Document Security Systems, Inc., a New York corporation (the \"Issuer\") closed on a share exchange agreement (the \"Exchange Agreement\") by and among the Issuer, DSS BioHealth Security, Inc., Singapore eDevelopment Ltd. (\"SeD\"), an entity controlled by the Reporting Person, and Global Biomedical Pte Ltd. (\"GBM\"), a wholly-owned subsidiary of SeD. Pursuant to the Exchange Agreement, GBM received 483,334 shares of the Issuer's common stock at a per share cost basis of $6.48 per share. The Reporting Person has dispositive control over these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On August 21, 2020, Document Security Systems, Inc., a New York corporation (the \"Issuer\") closed on a share exchange agreement (the \"Exchange Agreement\") by and among the Issuer, DSS BioHealth Security, Inc., Singapore eDevelopment Ltd. (\"SeD\"), an entity controlled by the Reporting Person, and Global Biomedical Pte Ltd. (\"GBM\"), a wholly-owned subsidiary of SeD. Pursuant to the Exchange Agreement, GBM received 483,334 shares of the Issuer's common stock at a per share cost basis of $6.48 per share. The Reporting Person has dispositive control over these securities."}],"balance_after":483334,"source":{"system":"sec-edgar","filing":"0001493152-20-016707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220016707/ownership.xml","form_type":"4"}},{"id":3225709,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-05T11:15:18.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":11111112,"price":0.18,"value":2000000.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on February 27, 2020 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of Common Stock. No other changes have been made to the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 24, 2020, the Reporting Persons purchased from the Issuer 11,111,112 shares of the Issuer's Common Stock, in an underwritten public offering, in consideration for $2,000,000."}],"balance_after":13538711,"source":{"system":"sec-edgar","filing":"0001493152-20-003408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220003408/ownership.xml","form_type":"4/A","original_submission_date":"2020-02-27"}},{"id":3245150,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-28T00:36:15.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":11111111,"price":0.18,"value":1999999.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2020, the Reporting Persons purchased from the Issuer 11,111,111 shares of the Issuer's Common Stock, in an underwritten public offering, in consideration for $2,000,000."}],"balance_after":13538710,"source":{"system":"sec-edgar","filing":"0001493152-20-003100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220003100/ownership.xml","form_type":"4"}},{"id":3257989,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-21T18:34:00.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":349917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Executive Employment Agreement between the Issuer and\nthe Reporting Person and the Issuer's 2020 Equity Incentive Plan, in consideration for the Reporting Person's services as Executive Chairman of the Issuer and\nExecutive Chairman and Chief Executive Officer of the Issuer's subsidiary."}],"balance_after":2427599,"source":{"system":"sec-edgar","filing":"0001493152-20-002815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315220002815/ownership.xml","form_type":"4"}},{"id":3381187,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T21:30:11.000Z","date":"2019-11-01","kind":"purchase","acquired":true,"shares":6000000,"price":0.3037,"value":1822200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2019, Document Security Systems, Inc., a New York corporation (the \"Company\") entered into and closed on a subscription agreement (the \"Subscription Agreement\") with LiquidValue Development Pte Ltd., an entity owned and controlled by the Reporting Person. Pursuant to the Subscription Agreement, LiquidValue Development Pte Ltd. purchased 6,000,000 shares of the Company's common stock at a purchase price of $0.3037 per share. The Reporting Person has dispositive control over these securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 1, 2019, Document Security Systems, Inc., a New York corporation (the \"Company\") entered into and closed on a subscription agreement (the \"Subscription Agreement\") with LiquidValue Development Pte Ltd., an entity owned and controlled by the Reporting Person. Pursuant to the Subscription Agreement, LiquidValue Development Pte Ltd. purchased 6,000,000 shares of the Company's common stock at a purchase price of $0.3037 per share. The Reporting Person has dispositive control over these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On November 1, 2019, Document Security Systems, Inc., a New York corporation (the \"Company\") entered into and closed on a subscription agreement (the \"Subscription Agreement\") with LiquidValue Development Pte Ltd., an entity owned and controlled by the Reporting Person. Pursuant to the Subscription Agreement, LiquidValue Development Pte Ltd. purchased 6,000,000 shares of the Company's common stock at a purchase price of $0.3037 per share. The Reporting Person has dispositive control over these securities."}],"balance_after":6446428,"source":{"system":"sec-edgar","filing":"0001493152-19-016463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219016463/ownership.xml","form_type":"4"}},{"id":3456395,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155857,"kind":"person","name":"Lo Wah Wai","position":1,"cik":"0001774219","reported_name":"Lo Wah Wai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-25T12:30:41.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":40767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":40767,"source":{"system":"sec-edgar","filing":"0001493152-19-011080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011080/ownership.xml","form_type":"4"}},{"id":3457125,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155886,"kind":"person","name":"Grisham Stanley V.","position":1,"cik":"0001776112","reported_name":"Grisham Stanley V.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T22:21:50.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":30575,"source":{"system":"sec-edgar","filing":"0001493152-19-011064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011064/ownership.xml","form_type":"4"}},{"id":3457124,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155885,"kind":"person","name":"Avallone Pamela","position":1,"cik":"0001716182","reported_name":"Avallone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T22:19:46.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":30575,"source":{"system":"sec-edgar","filing":"0001493152-19-011063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011063/ownership.xml","form_type":"4"}},{"id":3457123,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":95125,"kind":"person","name":"THATCH JOHN","position":1,"cik":"0001733061","reported_name":"THATCH JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T22:15:01.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":30575,"source":{"system":"sec-edgar","filing":"0001493152-19-011062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011062/ownership.xml","form_type":"4"}},{"id":3457122,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":55983,"kind":"person","name":"Grady Jason","position":1,"cik":"0001782482","reported_name":"Grady Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-07-24T22:13:07.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":74770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Chief Operating Officer of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Chief Operating Officer of the Issuer."}],"balance_after":74770,"source":{"system":"sec-edgar","filing":"0001493152-19-011061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011061/ownership.xml","form_type":"4"}},{"id":3457129,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":85298,"kind":"person","name":"Heuszel Frank D","position":1,"cik":"0001748704","reported_name":"Heuszel Frank D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-24T22:03:45.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":74770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Chief Executive Officer, Interim Chief Financial Officer and Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Chief Executive Officer, Interim Chief Financial Officer and Director of the Issuer."}],"balance_after":74770,"source":{"system":"sec-edgar","filing":"0001493152-19-011060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011060/ownership.xml","form_type":"4"}},{"id":3457117,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T22:01:34.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":74770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Executive Chairman of the Issuer and Executive Chairman and Chief Executive Officer of the Issuer's subsidiary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as Executive Chairman of the Issuer and Executive Chairman and Chief Executive Officer of the Issuer's subsidiary."}],"balance_after":2077682,"source":{"system":"sec-edgar","filing":"0001493152-19-011057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011057/ownership.xml","form_type":"4"}},{"id":3457127,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155887,"kind":"person","name":"DelGiorno Daniel","position":1,"cik":"0001768218","reported_name":"DelGiorno Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T21:59:59.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":40767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":40767,"source":{"system":"sec-edgar","filing":"0001493152-19-011054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011054/ownership.xml","form_type":"4"}},{"id":3457116,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155884,"kind":"person","name":"Scott Brett L","position":1,"cik":"0001405195","reported_name":"Scott Brett L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T21:58:06.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":30575,"source":{"system":"sec-edgar","filing":"0001493152-19-011052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011052/ownership.xml","form_type":"4"}},{"id":3457115,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T21:56:23.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a stock grant awarded to the Reporting Person by the Issuer pursuant to the Company's 2013 Employee, Director and Consultants Equity Incentive Plan in consideration for the Reporting Person's services as a Director of the Issuer."}],"balance_after":684970,"source":{"system":"sec-edgar","filing":"0001493152-19-011049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219011049/ownership.xml","form_type":"4"}},{"id":3496475,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T21:00:37.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":2000000,"price":0.5,"value":1000000.0,"ownership":{"direct":true},"balance_after":2002912,"source":{"system":"sec-edgar","filing":"0001493152-19-008945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219008945/ownership.xml","form_type":"4"}},{"id":3496474,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T21:00:22.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":1181,"price":0.4755,"value":561.5655,"ownership":{"direct":true},"balance_after":654395,"source":{"system":"sec-edgar","filing":"0001493152-19-008942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219008942/ownership.xml","form_type":"4"}},{"id":3517585,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-21T20:05:40.000Z","date":"2019-05-20","kind":"purchase","acquired":true,"shares":3181,"price":1.05,"value":3340.05,"ownership":{"direct":true},"balance_after":653214,"source":{"system":"sec-edgar","filing":"0001493152-19-008000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219008000/ownership.xml","form_type":"4"}},{"id":3579196,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2019-03-26T20:21:39.000Z","date":"2019-03-25","kind":"exercise","acquired":false,"shares":446428,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On March 25, 2019, a Convertible Promissory Note in the amount of $500,000 was converted into 446,428 shares of the common stock of Document Security Systems, Inc. These shares are held by LiquidValue Development Pte Ltd, of which the Reporting Person is the owner and a director. The Reporting Person has dispositive control over these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On March 25, 2019, a Convertible Promissory Note in the amount of $500,000 was converted into 446,428 shares of the common stock of Document Security Systems, Inc. These shares are held by LiquidValue Development Pte Ltd, of which the Reporting Person is the owner and a director. The Reporting Person has dispositive control over these shares."}],"balance_after":0,"derivative":{"exercise_price":1.12,"exercise_date":"2019-02-18","expiration_date":"2020-02-18","underlying":"Common","underlying_shares":446428},"source":{"system":"sec-edgar","filing":"0001493152-19-003944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219003944/ownership.xml","form_type":"4"}},{"id":3579195,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-26T20:21:39.000Z","date":"2019-03-25","kind":"exercise","acquired":true,"shares":446428,"price":1.12,"value":499999.36,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On March 25, 2019, a Convertible Promissory Note in the amount of $500,000 was converted into 446,428 shares of the common stock of Document Security Systems, Inc. These shares are held by LiquidValue Development Pte Ltd, of which the Reporting Person is the owner and a director. The Reporting Person has dispositive control over these shares."}],"balance_after":446428,"source":{"system":"sec-edgar","filing":"0001493152-19-003944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219003944/ownership.xml","form_type":"4"}},{"id":3609938,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155887,"kind":"person","name":"DelGiorno Daniel","position":1,"cik":"0001768218","reported_name":"DelGiorno Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.02 per share","published_at":"2019-03-06T21:15:13.000Z","date":"2019-03-05","kind":"other","acquired":true,"shares":130435,"price":1.15,"value":150000.25,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock was issued as partial consideration for a licensing contract between the Issuer and Advanced Cyber Security Corp. The Reporting Person is a principal and the Chief Executive Officer of Advanced Cyber Security Corp. and is also a member of Issuer's Board of Directors. Reporting Person has dispositive control over the shares issued."}],"balance_after":130435,"source":{"system":"sec-edgar","filing":"0001493152-19-002934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219002934/ownership.xml","form_type":"4"}},{"id":3647968,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2019-02-20T23:22:42.000Z","date":"2019-02-18","kind":"purchase","acquired":true,"shares":446428,"ownership":{"direct":false,"nature":"Through LiquidValue Development Pte Ltd. See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Convertible Promissory Note in the amount of $500,000, convertible into 446,428 shares of Common Stock, is held by LiquidValue Development Pte Ltd of which Reporting Person is the owner and a director. The Reporting Person has dispositive control over these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Convertible Promissory Note in the amount of $500,000, convertible into 446,428 shares of Common Stock, is held by LiquidValue Development Pte Ltd of which Reporting Person is the owner and a director. The Reporting Person has dispositive control over these securities."}],"balance_after":446428,"derivative":{"exercise_price":1.12,"exercise_date":"2019-02-18","expiration_date":"2020-02-18","underlying":"Common","underlying_shares":446428},"source":{"system":"sec-edgar","filing":"0001493152-19-002324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315219002324/ownership.xml","form_type":"4"}},{"id":3728207,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T21:45:26.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":612245,"price":0.98,"value":600000.1,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Heng Fai Holdings Limited of which Reporting Person is the owner. The Reporting Person has dispositive control over these securities."}],"balance_after":1786531,"source":{"system":"sec-edgar","filing":"0001493152-18-017673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218017673/ownership.xml","form_type":"4"}},{"id":3873519,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T21:00:27.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":214286,"price":1.4,"value":300000.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Heng Fai Holdings Limited, of which Reporting Person is an officer and the owner. The Reporting Person has dispositive control over these securities."}],"balance_after":1174286,"source":{"system":"sec-edgar","filing":"0001493152-18-009731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218009731/form4.xml","form_type":"4"}},{"id":3963645,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":167558,"kind":"person","name":"LERNER WILLIAM","position":1,"cik":"0001018370","reported_name":"LERNER WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:50:27.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of his services as a Director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":10000,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005245/form4.xml","form_type":"4"}},{"id":3963643,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:30:21.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of his services as a Director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":90000,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005241","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005241/form4.xml","form_type":"4"}},{"id":3963642,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":142866,"kind":"person","name":"Marcus Clark A.","position":1,"cik":"0001422478","reported_name":"Marcus Clark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:30:21.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of his services as a Director of the company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":10000,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005240","document":"form-4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005240/form-4.xml","form_type":"4"}},{"id":3963641,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155885,"kind":"person","name":"Avallone Pamela","position":1,"cik":"0001716182","reported_name":"Avallone Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:30:19.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of her services as a Director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":10000,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005237","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005237/form4.xml","form_type":"4"}},{"id":3963640,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":167557,"kind":"person","name":"Hurwitz Warren","position":1,"cik":"0001580363","reported_name":"Hurwitz Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:30:19.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of his services as a Director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":17500,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005238/form4.xml","form_type":"4"}},{"id":3963639,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":52546,"kind":"person","name":"FAGENSON ROBERT B","position":1,"cik":"0001215183","reported_name":"FAGENSON ROBERT B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-04-16T20:30:19.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options grant was made to the Reporting Person in consideration of his services as a Director of the company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options granted to the Reporting Person under the Company's Employee, Director and Consultant Equity Incentive Plan. The options vest 1/3 on 4/12/18, 1/3 on 4/12/19 and 1/3 on 4/12/20. The options grant expires on 4/12/23."}],"balance_after":40421,"derivative":{"exercise_price":1.3,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-005236","document":"form-4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218005236/form-4.xml","form_type":"4"}},{"id":3979036,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-03-30T21:00:12.000Z","date":"2018-03-30","kind":"purchase","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock and warrants issued on March 30, 2018 Pursuant to a Securities Purchase Agreement executed on August 30, 2017. The Reporting Person completed the Purchase of the contracted for shares and warrants on March 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price of the warrants is included in the price of the shares reported on Table I."}],"balance_after":80000,"derivative":{"exercise_price":1,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-18-004281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218004281/form4.xml","form_type":"4"}},{"id":3979035,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-30T21:00:12.000Z","date":"2018-03-30","kind":"purchase","acquired":true,"shares":400000,"price":0.75,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock and warrants issued on March 30, 2018 Pursuant to a Securities Purchase Agreement executed on August 30, 2017. The Reporting Person completed the Purchase of the contracted for shares and warrants on March 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock and warrants issued on March 30, 2018 Pursuant to a Securities Purchase Agreement executed on August 30, 2017. The Reporting Person completed the Purchase of the contracted for shares and warrants on March 30, 2018."}],"balance_after":650033,"source":{"system":"sec-edgar","filing":"0001493152-18-004281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218004281/form4.xml","form_type":"4"}},{"id":3985768,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-03-22T20:50:26.000Z","date":"2018-03-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to the Reporting Person from Issuer's 2013 Employee, Director and Consultant Equity Incentive plan as a common stock bonus pursuant to the terms of the Employment Agreement dated December 30,2016 between the Issuer and the Reporting Person."}],"balance_after":520603,"source":{"system":"sec-edgar","filing":"0001493152-18-003757","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315218003757/form4.xml","form_type":"4"}},{"id":4130946,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-12-15T21:05:22.000Z","date":"2017-12-13","kind":"other","acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Heng Fai Holdings Limited, of which Reporting Person is an Officer and the owner. The Reporting Person has dispositive control over these securities."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-09-08","expiration_date":"2022-09-08","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-17-014651","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217014651/form4.xml","form_type":"4"}},{"id":4130945,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T21:05:22.000Z","date":"2017-12-13","kind":"other","acquired":true,"shares":160000,"price":1,"value":160000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Heng Fai Holdings Limited, of which Reporting Person is an Officer and the owner. The Reporting Person has dispositive control over these securities."}],"balance_after":960000,"source":{"system":"sec-edgar","filing":"0001493152-17-014651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217014651/form4.xml","form_type":"4"}},{"id":4139735,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T21:45:28.000Z","date":"2017-12-05","kind":"purchase","acquired":true,"shares":300,"price":1.15,"value":345.0,"ownership":{"direct":true},"balance_after":2912,"source":{"system":"sec-edgar","filing":"0001493152-17-014312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217014312/form4.xml","form_type":"4"}},{"id":4155537,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2017-11-21T22:00:19.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":6900,"price":0.73,"value":5037.0,"ownership":{"direct":true},"balance_after":470603,"source":{"system":"sec-edgar","filing":"0001493152-17-013689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217013689/form4.xml","form_type":"4"}},{"id":4155536,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2017-11-21T22:00:19.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":5000,"price":0.72,"value":3600.0,"ownership":{"direct":true},"balance_after":463703,"source":{"system":"sec-edgar","filing":"0001493152-17-013689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217013689/form4.xml","form_type":"4"}},{"id":4157361,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2017-11-20T22:15:23.000Z","date":"2017-11-17","kind":"purchase","acquired":true,"shares":27000,"price":0.69,"value":18630.0,"ownership":{"direct":true},"balance_after":458703,"source":{"system":"sec-edgar","filing":"0001493152-17-013628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217013628/form4.xml","form_type":"4"}},{"id":4157360,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2017-11-20T22:15:23.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":109400,"price":0.66,"value":72204.0,"ownership":{"direct":true},"balance_after":431703,"source":{"system":"sec-edgar","filing":"0001493152-17-013628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217013628/form4.xml","form_type":"4"}},{"id":4204452,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2017-09-21T20:45:11.000Z","date":"2017-09-19","kind":"tax_withholding","acquired":true,"shares":11364,"price":0.75,"value":8523.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2016-04-22","expiration_date":"2020-04-22","underlying":"Common Stock","underlying_shares":11364},"source":{"system":"sec-edgar","filing":"0001493152-17-010812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010812/form4.xml","form_type":"4"}},{"id":4204451,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-21T20:45:11.000Z","date":"2017-09-19","kind":"tax_withholding","acquired":true,"shares":11364,"price":0.75,"value":8523.0,"ownership":{"direct":true},"balance_after":250033,"source":{"system":"sec-edgar","filing":"0001493152-17-010812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010812/form4.xml","form_type":"4"}},{"id":4209813,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-09-14T20:45:20.000Z","date":"2017-09-12","kind":"tax_withholding","acquired":true,"shares":200000,"price":0.75,"value":150000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Held by BMI Capital Partners International Limited., of which the Reporting Person is a director. The Reporting Person has dispositive control over these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by BMI Capital Partners International Limited., of which the Reporting Person is a director. The Reporting Person has dispositive control over these securities."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2016-12-29","expiration_date":"2019-12-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-17-010616","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010616/form4.xml","form_type":"4"}},{"id":4209812,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T20:45:20.000Z","date":"2017-09-12","kind":"other","acquired":true,"shares":683000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"As consideration for the shares of the Issuer acquired on 09/12/2017 and that were valued at $0.71 per share, Hengfai Business Develoment Pte Ltd. exchanged securities of an entity listed on the Singapore Exchange Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Hengfai Business Develoment Pte Ltd., of which the Reporting Person is the Chief Executive Officer and the owner. The Reporting Person has dispositive control over these securities."}],"balance_after":683000,"source":{"system":"sec-edgar","filing":"0001493152-17-010616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010616/form4.xml","form_type":"4"}},{"id":4209811,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T20:45:20.000Z","date":"2017-09-12","kind":"tax_withholding","acquired":true,"shares":200000,"price":0.75,"value":150000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by BMI Capital Partners International Limited., of which the Reporting Person is a director. The Reporting Person has dispositive control over these securities."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001493152-17-010616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010616/form4.xml","form_type":"4"}},{"id":4212281,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2017-09-12T21:00:14.000Z","date":"2017-09-08","kind":"purchase","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price of the warrants is included in the price of the shares reported in Table I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"BMI capital owns the previously issued warrants to purchase 200,000 shares of the Issuer's common stock. HF Holdings owns the warrants to purchase 160,000 shares of Issuer's common stock. Reporting Person has dispositive control over all of these warrants."}],"balance_after":160000,"derivative":{"exercise_price":1,"exercise_date":"2017-09-08","expiration_date":"2022-09-08","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-17-010498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010498/form4.xml","form_type":"4"}},{"id":4212280,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":24553,"kind":"person","name":"Chan Heng Fai Ambrose","position":1,"cik":"0001261725","reported_name":"Chan Heng Fai Ambrose","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-12T21:00:14.000Z","date":"2017-09-08","kind":"purchase","acquired":true,"shares":800000,"price":0.75,"value":600000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a director of BMI Capital Partners International Ltd. (\"BMI Capital\"), which owns 300,000 shares of the Issuer's common stock purchased on 12/29/16. The Reporting Person is also the CEO and majority shareholder of Heng Fai Holdings Limited (\"HF Holdings\"), which owns the 800,000 shares of Issuer's common stock purchased on 9/8/17. Reporting Person has dispositive control over all of these shares."}],"balance_after":1100000,"source":{"system":"sec-edgar","filing":"0001493152-17-010498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217010498/form4.xml","form_type":"4"}},{"id":4227041,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-23T20:15:36.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":6235,"price":0.75,"value":4676.25,"ownership":{"direct":true},"balance_after":322303,"source":{"system":"sec-edgar","filing":"0001493152-17-009764","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009764/form4.xml","form_type":"4"}},{"id":4227040,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-23T20:15:36.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":500,"price":0.73,"value":365.0,"ownership":{"direct":true},"balance_after":316068,"source":{"system":"sec-edgar","filing":"0001493152-17-009764","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009764/form4.xml","form_type":"4"}},{"id":4227039,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-23T20:15:36.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":26,"price":0.72,"value":18.72,"ownership":{"direct":true},"balance_after":315568,"source":{"system":"sec-edgar","filing":"0001493152-17-009764","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009764/form4.xml","form_type":"4"}},{"id":4227038,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-23T20:15:36.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":5739,"price":0.71,"value":4074.69,"ownership":{"direct":true},"balance_after":315542,"source":{"system":"sec-edgar","filing":"0001493152-17-009764","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009764/form4.xml","form_type":"4"}},{"id":4228997,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-21T20:15:35.000Z","date":"2017-08-18","kind":"purchase","acquired":true,"shares":1535,"price":0.67,"value":1028.45,"ownership":{"direct":true},"balance_after":309803,"source":{"system":"sec-edgar","filing":"0001493152-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009668/form4.xml","form_type":"4"}},{"id":4228996,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-21T20:15:35.000Z","date":"2017-08-18","kind":"purchase","acquired":true,"shares":4339,"price":0.66,"value":2863.74,"ownership":{"direct":true},"balance_after":308268,"source":{"system":"sec-edgar","filing":"0001493152-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009668/form4.xml","form_type":"4"}},{"id":4228995,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-21T20:15:35.000Z","date":"2017-08-18","kind":"purchase","acquired":true,"shares":6626,"price":0.68,"value":4505.68,"ownership":{"direct":true},"balance_after":303929,"source":{"system":"sec-edgar","filing":"0001493152-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217009668/form4.xml","form_type":"4"}},{"id":4491543,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-01-13T21:12:55.000Z","date":"2017-01-12","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to the Reporting Person from Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for services provided to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Common stock grant fully vested on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued to the Reporting Person from Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for services provided to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the Issuer on August 26, 2016."}],"balance_after":297303,"source":{"system":"sec-edgar","filing":"0001493152-17-000480","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217000480/form4.xml","form_type":"4"}},{"id":4491542,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":179693,"kind":"person","name":"Bzdick Robert B.","position":1,"cik":"0001484889","reported_name":"Bzdick Robert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-01-13T21:11:00.000Z","date":"2017-01-12","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to Reporting Person From Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for services previously provided to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Common Stock grant will vest on May 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued to Reporting Person From Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for services previously provided to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the Issuer on August 26, 2016."}],"balance_after":304996,"source":{"system":"sec-edgar","filing":"0001493152-17-000479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315217000479/form4.xml","form_type":"4"}},{"id":4517830,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T21:10:53.000Z","date":"2016-12-15","kind":"purchase","acquired":true,"shares":1250,"price":0.64,"value":800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the issuer on August 26, 2016."}],"balance_after":238669,"source":{"system":"sec-edgar","filing":"0001493152-16-016012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216016012/form4.xml","form_type":"4"}},{"id":4517831,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":180319,"kind":"person","name":"JONES PHILIP A","position":1,"cik":"0001109991","reported_name":"JONES PHILIP A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2016-12-19T21:10:28.000Z","date":"2016-12-15","kind":"purchase","acquired":true,"shares":10000,"price":0.66,"value":6600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the company on August 26, 2016."}],"balance_after":64688,"source":{"system":"sec-edgar","filing":"0001493152-16-016011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216016011/form4.xml","form_type":"4"}},{"id":4534429,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":52546,"kind":"person","name":"FAGENSON ROBERT B","position":1,"cik":"0001215183","reported_name":"FAGENSON ROBERT B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T21:46:11.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":1653,"price":0.698,"value":1153.794,"ownership":{"direct":true},"balance_after":297931,"source":{"system":"sec-edgar","filing":"0001493152-16-015663","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216015663/form4.xml","form_type":"4"}},{"id":4539586,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":52546,"kind":"person","name":"FAGENSON ROBERT B","position":1,"cik":"0001215183","reported_name":"FAGENSON ROBERT B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-30T21:23:23.000Z","date":"2016-11-28","kind":"purchase","acquired":true,"shares":2347,"price":0.7145,"value":1676.9315,"ownership":{"direct":true},"balance_after":296278,"source":{"system":"sec-edgar","filing":"0001493152-16-015540","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216015540/form4.xml","form_type":"4"}},{"id":4540760,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":155883,"kind":"person","name":"SANDERS JOSEPH L.","position":1,"cik":"0001655128","reported_name":"SANDERS JOSEPH L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-29T21:15:16.000Z","date":"2016-11-28","kind":"purchase","acquired":true,"shares":3000,"price":0.65,"value":1950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the issuer on August 26, 2016."}],"balance_after":237419,"source":{"system":"sec-edgar","filing":"0001493152-16-015516","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216015516/form4.xml","form_type":"4"}},{"id":4547914,"issuer":{"id":8811,"kind":"organization","name":"DSS, INC.","symbol":"DSS"},"owners":[{"id":168125,"kind":"person","name":"Ronaldi Jeffrey","position":1,"cik":"0001580473","reported_name":"Ronaldi Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2016-11-21T21:12:31.000Z","date":"2016-11-17","kind":"grant","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to the Reporting Person from Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for Services Provided to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Common stock grant will fully vest six months from the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued to the Reporting Person from Issuer's 2013 Employee, Director and Consultant Equity Incentive Plan for Services Provided to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount reflects a 1-for-4 reverse stock split which was affected by the company on August 26, 2016."}],"balance_after":272303,"source":{"system":"sec-edgar","filing":"0001493152-16-015336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771999/000149315216015336/form4.xml","form_type":"4"}}],"next_cursor":"2016-11-21T21:12:31.000000Z,4547914"}